Semaglutide is a long-acting GLP-1 receptor agonist that mimics the action of the naturally occurring incretin hormone GLP-1
Regular monitoring, dose adjustments, and medical guidance throughout your therapy journey
The concentrations of d9-carnitine and d9-TMAO in the samples were determined from the calibration curves using the peak area ratio of the analyte to its corresponding isotope internal standard
Targeting cancer metabolism in the era of precision oncology
Recently, the pharmacotherapy of MASLD mainly focuses on three parts of mechanisms: anti-inflammatory (ASK1 inhibitors), anti-diabetic (GCGR agonists, PPAR agonists), and prevention of lipotoxicity (FXR agonists, FGF21 analogues) (Wei et al., 2024)
At 10 mg/mL, it is 2.0 mg